Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Reabilitação para artrite do joelho: manutenção da melhoria para veteranos (ReAKTIV)

12 de novembro de 2026 atualizado por: VA Office of Research and Development

Uma intervenção comportamentalmente aplicada remotamente, incorporando gamificação, incentivos sociais e treinamento de saúde para melhorar a durabilidade da fisioterapia para osteoartrite do joelho (ReAKTIV)

The aims are to determine whether 1) an incentive based on behaviorally-enhanced gamification and social incentives and 2) health coaching can promote adherence to exercise and physical activity after physical therapy for osteoarthritis of the knee (KOA). The research design is a randomized clinical trial with factorial design

This randomized clinical trial of 254 patients using a factorial design will leverage a clinical trial platform developed through the University of Pennsylvania that allows for the remotely capture important patient-reported outcomes and other interaction through a participant's smart phone. The investigators will randomize participants to receive social incentives with gamification to promote adherence to prescribed exercises as well as maintenance of greater levels of physical activity and compare to controls that receive a Fitbit but no additional incentive. Participants may also be randomized to receive a health coach. The investigators will utilize mobile applications for smart phones and wearable activity trackers through the Way-to-Health platform and assess, in real time, the impact of the interventions on patient-reported function and pain (as measured by the Knee Osteoarthritis Outcome Score) as well as physical activity. Participants will be followed for 2 years, with a total of 5 in-person visits.

Knee osteoarthritis (KOA) is one of the most prevalent and disabling conditions among Veterans and accounts for high morbidity and high costs for the VA. Importantly, while physical therapy is valuable for patients with KOA, lack of adherence to home exercises and low overall physical activity limit the durability of response. The current proposal aims to address two important knowledge gaps in the management of KOA in order to improve pain and function.

Visão geral do estudo

Descrição detalhada

Knee osteoarthritis (KOA) is a high-priority problem among the aging population, and in particular, among Veterans. Few interventions have been shown effective in the long-term management of symptoms. Current guidelines for non-operative KOA management include strong recommendations for exercise delivered through standard physical therapy (PT) and the promotion of greater physical activity. Standard physical therapy (PT) interventions characterized by 6-8 week of supervised exercises (e.g., strengthening peri-articular tissues) and mobility training (e.g., improving biomechanics and movement patterns) are safe and effective at improving and facilitating mobility, activity participation, and overall quality of life. While PT is a recognized and necessary aspect of KOA care, its clinical benefits are often short-lived and begin to decline following PT due to poor long-term adherence - leading physicians to increasingly rely on the use of non-steroidal anti-inflammatories and opioids over time. The lack of effective strategies to sustain the clinical benefits achieved in PT for individuals with KOA remains a critical gap.

The investigators aim to study two interventions designed based on their ability to address 5 key theories for maintaining behaviors that are supported by the literature. Specifically, the proposed study will evaluate a remote and behaviorally-designed intervention in combination with health coaching to influence long-term behavioral change after standard-of-care PT. The behavioral intervention utilizes tools such as goal setting, gamification (the use of game design elements), loss aversion, monitoring, and social incentives, to 1) increase motivation, 2) improve self-monitoring and self-regulation, 3) provide psychological and physical resources, 4) influence the development of healthy long-term habits, and 5) a provide supportive environment with social support. The behavioral intervention will be studied combined with health coaching with a focus on the same goals but through motivational interviewing to address personal, environmental, and social barriers. The investigators aim to clearly quantify the value of each as well as their value when used in combination.

The investigators has already utilized concepts from behavioral economics (a scientific field aiming to understand how to motivate individuals) to develop remotely-applied interventions that incorporate the concepts of gamification, social incentives, and loss aversion to promote improvements in physical activity using an innovative web-based platform. The investigators SPiRE-funded pilot study "Marching On for Veterans with Osteoarthritis of the Knee" demonstrated excellent feasibility, rapid recruitment, improvements in reported symptoms, and high patient satisfaction. The multi-site study is actively enrolling Veterans and is ahead of schedule.

The investigators propose to fill important knowledge gaps in this area with a large, pragmatic clinical trial. In this study, the investigators will randomize in a factorial design to receive no intervention, the remote behavioral intervention, a remote health coach, or both, after being released from a standard PT intervention with proven efficacy in order to promote the maintenance of symptomatic gains observed during PT. To accomplish these aims, the investigators will utilize innovative mobile applications for smart phones through the Way-to-Health (WTH) platform and assess, in real time, the impact of the intervention on the primary outcome of patient-reported symptoms as measured by the Knee Osteoarthritis Outcome score. The investigators will also monitor adherence to specific knee-related exercises at home. Way to Health allows for the recording of outcomes in real time, as they occur, thereby avoiding information bias due to poor recall and participation bias. The investigative team includes investigators with experience conducting similar trials using this infrastructure as well as expertise in behavioral economics and motivational interviewing. The study also involves a centralized organizational structure in close collaboration with investigators across the country.

Aim 1: To determine if a personalized and remotely-applied behavioral intervention based on insights from behavioral economics can sustain the symptomatic gains following physical therapy for KOA. Hypothesis: A remotely-applied program will result in maintenance of higher KOOS scores after PT by promoting greater adherence, self-efficacy, habituation, and social support.

Aim 2: To determine if a remote health coach can sustain the symptomatic gains following physical therapy for KOA. Hypothesis: Those that are randomized to receive a health coach will maintain higher KOOS scores after PT.

Aim 3: To determine how the behavioral intervention and health coaching interventions interact with each other. Hypothesis: The effect of both interventions will be additive such that the greatest improvement in symptoms will occur among those that receive both interventions.

Tipo de estudo

Intervencional

Inscrição (Estimado)

254

Estágio

  • Fase 3

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

  • Nome: Joshua F Baker, MD MSCE
  • Número de telefone: (215) 823-5800
  • E-mail: Joshua.Baker@va.gov

Locais de estudo

    • Alabama
      • Birmingham, Alabama, Estados Unidos, 35233-1927
        • Ainda não está recrutando
        • Birmingham VA Medical Center, Birmingham, AL
        • Contato:
    • Nebraska
      • Omaha, Nebraska, Estados Unidos, 68105-1850
        • Ainda não está recrutando
        • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
        • Contato:
    • Oregon
      • Portland, Oregon, Estados Unidos, 97207-2964
        • Ainda não está recrutando
        • VA Portland Health Care System, Portland, OR
        • Contato:
    • Pennsylvania
      • Philadelphia, Pennsylvania, Estados Unidos, 19104-4551
        • Recrutamento
        • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA
        • Contato:
        • Investigador principal:
          • Joshua F. Baker, MD MSCE
    • Washington
      • Seattle, Washington, Estados Unidos, 98108-1532
        • Ainda não está recrutando
        • VA Puget Sound Health Care System Seattle Division, Seattle, WA
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

40 anos a 90 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Clinical diagnosis or chronic knee osteoarthritis.
  • Age between 40-90 years
  • Initiating physical therapy for KOA (has initial appointment within the next month or had first PT visit within the last 7 days)
  • To be randomized: PT feels that they are able to safely and reliably participate in ongoing exercise.
  • To be randomized: must have completed at least 4 virtual or in-person appointments with PT
  • To be randomized: must sync their Fitbit at least monthly.

Exclusion Criteria:

  • Lack of a smart phone allowing interaction with the WTH platform
  • Inability to walk 2 blocks without assistance
  • Poorly controlled crystalline arthritis or other diagnosis of inflammatory arthritis.
  • Treating provider or LSI believes life-expectancy is <1 year
  • Based on LSI or treating provider discretion: exclusions may occur for severe heart failure, unstable angina, end stage renal disease, severe chronic obstructive or other pulmonary disease, or other chronic illness felt to limit participants ability to participate in exercise or resulting in potential safety risk
  • Severe pain in a non-knee area limiting daily function
  • Non-English speakers or poor reading ability limiting ability to interact with text messages.
  • Pregnancy
  • Receiving physical therapy outside of the VA.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição fatorial
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Sem intervenção: No Intervention

Neither Intervention

Experimental: Health Coaching, No Incentives

Receives a Health Coach but no Incentive Program

Health Coaching

Experimental: No Health Coach, Receives Incentives

Does not receive a health coach but does receive the incentive program.

Behavioral incentive program including gamification, social incentivization, and monitoring.

Experimental: Health Coaching, Receives Incentives

Receives both a health coach and the incentive program

Health Coaching

Behavioral incentive program including gamification, social incentivization, and monitoring.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
KOOS (Knee Osteoarthritis Outcome Score)
Prazo: all available measures between 6-18 months (time-averaged effect)

The KOOS score is a validated and widely used measure of knee-related pain and physical functioning that has been validated in both knee injury and KOA populations. The KOOS measures symptoms and disability on five subscales: Pain, other Symptoms, Function in Activities of Daily Living, Function in Sports and Recreation, and Quality of Life (QOL). Range is from 0-100 for each subscale with lower scores suggesting worse patient experience.

all available measures between 6-18 months (time-averaged effect)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Average Daily Step Counts
Prazo: 0-18 Months

Change in average daily step counts (averaged over the prior month) throughout follow-up (time-averaged effect).

0-18 Months
Change in Self Efficacy for excercise
Prazo: 6-18 months

Self-efficacy for exercise scale (change from baseline; time-averaged effect). Range 0-100 with higher scores representing more confidence in exercise.

6-18 months
Change in gait speed
Prazo: 6-18 months

Change in walking speed over a 4 meter testing zone (time-averaged effect)

6-18 months
30 second sit-to-stand
Prazo: 6-18 months

Number of times a person can stand and sit within 30 seconds (time-averaged effect)

6-18 months
Patient Reported Outcomes Measurement Information System Pain Intensity
Prazo: 6-18 Months

Change from baseline in PROMIS Pain Intensity (time-averaged effect). Scale 0-100 (higher score indicates more pain).

6-18 Months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Joshua F. Baker, MD MSCE, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

10 de dezembro de 2025

Conclusão Primária (Estimado)

31 de maio de 2029

Conclusão do estudo (Estimado)

1 de janeiro de 2030

Datas de inscrição no estudo

Enviado pela primeira vez

28 de junho de 2024

Enviado pela primeira vez que atendeu aos critérios de CQ

28 de junho de 2024

Primeira postagem (Real)

5 de julho de 2024

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de janeiro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • F4770-R
  • 1I01RX004770-01A2 (Concessão/Contrato do NIH dos EUA)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever